Search

Your search keyword '"Immunological adjuvants -- Testing"' showing total 18 results
Start Over Descriptor "Immunological adjuvants -- Testing" Publisher newsrx llc
18 results on '"Immunological adjuvants -- Testing"'

1. Researchers from Providence Cancer Institute Report Findings in Cancer Immunotherapy [Combining Bempegaldesleukin (Cd122-preferential Il-2 Pathway Agonist) and Nktr-262 (Tlr7/8 Agonist) Improves Systemic Antitumor Cd8(+) T Cell Cytotoxicity Over ...]

Subjects
Testing, Research, Health aspects, Cancer treatment -- Testing, Prodrugs -- Testing, Immunologic adjuvants -- Testing, Cell death -- Research, Immunotherapy -- Testing, Radiotherapy -- Testing, Therapeutics research, T cells -- Health aspects, Combined modality therapy -- Testing, Immunological adjuvants -- Testing, Cancer -- Care and treatment, Therapeutics, Experimental
Abstract

2022 MAY 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Drugs and Therapies - Cancer Immunotherapy is now [...]

Published
2022

2. New Clinical Trials and Studies Study Findings Recently Were Reported by Researchers at Medical University of South Carolina (Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric Il-15 Superagonist, In Healthy Volunteers)

Subjects
Testing, Research, Pharmaceutical research, Immunologic adjuvants -- Testing, Antineoplastic agents -- Testing, Pharmacokinetics -- Research, Immunological adjuvants -- Testing, Antimitotic agents -- Testing
Abstract

2022 APR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Clinical Research - Clinical Trials and Studies have been [...]

Published
2022

3. Studies from Universidad Autonoma de Nuevo Leon in the Area of Immunoglobulins Described (Development of a new generation of miniemulsion based on cottonseed oil with a-tocopherol and ZnO and evaluation of its adjuvant activity)

Subjects
Testing, Usage, Health aspects, Cottonseed oil -- Usage -- Health aspects, Nanoparticles -- Usage -- Health aspects, Alpha-tocopherol -- Usage -- Health aspects, Immunologic adjuvants -- Testing, Emulsions -- Usage -- Health aspects, Zinc oxide -- Usage -- Health aspects, Alpha tocopherol -- Usage -- Health aspects, Immunological adjuvants -- Testing
Abstract

2023 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Investigators publish new report on immunoglobulins. According to news reporting from Nuevo Leon, Mexico, [...]

Published
2023

4. New Cytokines Research Reported from Chinese Academy of Sciences (Rapid and Highly Efficient Genetic Transformation and Application of Interleukin-17B Expressed in Duckweed as Mucosal Vaccine Adjuvant)

Subjects
Testing, Usage, Physiological aspects, Genetic aspects, Health aspects, Interleukin-17 -- Health aspects -- Genetic aspects, Genetic transformation -- Physiological aspects, Medicinal plants -- Usage -- Health aspects -- Genetic aspects, Immunologic adjuvants -- Testing, Lemnaceae -- Health aspects -- Usage -- Genetic aspects, Immunological adjuvants -- Testing
Abstract

2023 JAN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Research findings on cytokines are discussed in a new report. According to news originating [...]

Published
2023

5. IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered With Protein Immunogens

Subjects
AIDS (Disease) -- Research, Pharmaceutical industry -- Research, Antiviral agents -- Research, Interleukin-1 -- Physiological aspects, Biological products industry -- Research, Immunological adjuvants -- Testing, Cholera toxin -- Physiological aspects
Abstract

Mucosal Immunization Staats, H.F.; Ennis, F.A. "IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered With Protein Immunogens." Journal of Immunology, May 15, 1999;162(10):6141-6147. (CW HENDERSON [...]

Published
1999

6. New mucosal adjuvant safe in humans

Author

DeNoon, Daniel J.

Subjects
Immunological adjuvants -- Testing, Enterotoxins -- Health aspects
Abstract

A new mucosal vaccine adjuvant designed for use with killed pathogens proved safe in humans. Tolerable dosages of the adjuvant, dubbed LT[R192G], were well within the range expected to be [...]

Published
1997

7. Use of Pharmos adjuvant to improve delivery of HIV vaccine

Subjects
Pharmos Corp. -- Product information, Immunological adjuvants -- Testing, AIDS vaccines -- Dosage and administration
Abstract

DATELINE: Walter Reed Army Institute Colonel George Lowell of the Walter Reed Army Institute of Research presented the results of studies on a novel formulation of the HIV gp160 vaccine [...]

Published
1993

8. New therapy for lung, kidney cancer being tested

Subjects
Testing, Lung cancer, Kidney cancer, Chemotherapy, Immunologic adjuvants -- Testing, Interleukin-4 -- Testing, Immunological adjuvants -- Testing, Cancer -- Chemotherapy
Abstract

Illinois Physicians at the University of Chicago Medical Center, Chicago, Illinois, are about to initiate a PhaseII clinical trial of interleukin-4, a recently discovered immune system stimulant that may prove [...]

Published
1992

9. Novel monoclonal antibody-based vaccine adjuvant found to significantly enhance immune response

Subjects
Medarex Inc. -- Product development, Immunological adjuvants -- Testing, Immune response -- Regulation, Monoclonal antibodies -- Health aspects
Abstract

Italy A novel vaccine adjuvant employing a monoclonal antibody has been demonstrated to significantly enhance an immune response to tetanus virus in pre-clinical studies, it was reported in Brindisi, Italy, [...]

Published
1992

10. Mannan-coated liposomes have an adjuvant effect on DNA vaccines

Author

Marble, Michelle

Subjects
AIDS vaccines -- Physiological aspects, Immunological adjuvants -- Testing
Abstract

A mannan coating on the cationic liposomes of an HIV DNA vaccine enhanced its immune potential. Mannose is a carbohydrate moiety that coats the surfaces of many infectious agents including [...]

Published
1997

11. Phase I trial of immunological adjuvant QS-21 with a GM2 ganglioside-KLH conjugate vaccine in patients with malignant melanoma

Author

Helling, F., Livingston, P.O., Adluri, S., Shang, A., Yao, T.-J., Kensil, C.R., Newman, M.J., and Marciani, D.

Subjects
Testing, Care and treatment, Immunologic adjuvants -- Testing, Melanoma -- Care and treatment, Immunological adjuvants -- Testing
Abstract

AUTHORS: F. Helling, P.O. Livingston, S. Adluri, A. Shang, T.-J. Yao, C.R. Kensil, M.J. Newman and D. Marciani. Memorial Sloan-Kettering Cancer Center, New York, New York and Cambridge Biotech Corporation, [...]

Published
1994

12. Stimulon adjuvant in Phase I trial with Genentech HIV-1 vaccine

Subjects
Aquila Biopharmaceuticals Inc. -- Product development, Genentech Inc. -- Product development, Immunological adjuvants -- Testing, AIDS vaccines -- Testing
Abstract

DATELINE: Massachusetts/California Cambridge Biotech Corporation, Worcester, Massachusetts, announced that its Stimulon QS*21 adjuvant is being used in a vaccine developed by Genentech Inc., South San Francisco, California, against HIV*1 (rsgp120/HIV*1). [...]

Published
1993

13. Liposome-encapsulated MTP-PE: a novel biologic for cancer therapy

Author

Kleinerman, E.S., Asano, T., Gano, J.B., Johnston, D., Benjamin, R.S., and Jaffe, N.

Subjects
Testing, Immunologic adjuvants -- Testing, Immunotherapy -- Testing, Immunological adjuvants -- Testing
Abstract

AUTHORS: E.S. Kleinerman, T. Asano, J.B. Gano, D. Johnston, R.S. Benjamin and N. Jaffe. The University of Texas, M.D. Anderson Cancer Center, Houston, Texas. According to an abstract presented by [...]

Published
1993

14. Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin-2 in patients with human immunodeficiency virus type-1 infection

Subjects
Immunological adjuvants -- Testing, Interleukin-2 -- Physiological aspects, HIV infection -- Drug therapy
Abstract

Relatively low doses of a new long-acting polyethylene glycolated form of recombinant interleukin-2 (PEG IL-2) have a prolonged immunostimulatory effect in HIV+ individuals, a preliminary clinical trial demonstrates. There is [...]

Published
1993

15. A Phase-I study of Ampligen in human immunodeficiency virus-infected subjects

Subjects
Ampligen (Medication) -- Testing, Immunological adjuvants -- Testing, HIV infection -- Drug therapy
Abstract

SOURCE: Journal of Infectious Diseases, October 1992;166(4):717-722. A Phase 1 dose-ranging study of Ampligen suggests that the drug may delay the decline of CD4+ T-cell counts in people with HIV [...]

Published
1992

17. Wobe-Mugos, Wobenzym

Author

DeNoon, Daniel J.

Subjects
Wobe-Mugos (Medication) -- Testing, Testing, Drug therapy, HIV infections -- Drug therapy, Immunologic adjuvants -- Testing, Enzymes -- Testing, Immunological adjuvants -- Testing, HIV infection -- Drug therapy
Abstract

WOBE-MUGOS, WOBENZYM. Also Known As: hydrolytic enzymes. Manufacturer: Mucos-Pharma Co., Geretsried, Germany. FDA Status: IND application submitted. Wobe-Mugos, or Wobenzym, is composed of proteolytic enzymes from animal and vegetable materials. [...]

Published
1990

18. AM3

Author

DeNoon, Daniel J.

Subjects
Immunoferon (Medication) -- Testing, Testing, Drug therapy, AIDS (Disease) -- Drug therapy, Immunologic adjuvants -- Testing, Immunological adjuvants -- Testing
Abstract

AM3. Trade Name: Inmunoferon. Chemical Name: glycophosphopeptical. Manufacturer: Laboratorios Andromaco S.A., Madrid, Spain. FDA Status: None. AM3 is described by its manufacturer as 'an immunostimulant drug chemically described as a [...]

Published
1990

Catalog

Books, media, physical & digital resources
See catalog results